Treatment of Herpes Labialis by Photodynamic Therapy (Herpes)
Photodynamic Therapy, Herpes Simplex, Labial
About this trial
This is an interventional treatment trial for Photodynamic Therapy focused on measuring photodynamic therapy, herpes labialis, herpes simplex, laser
Eligibility Criteria
Inclusion Criteria:
- Patients of both sex,
- with no predilection for race or socioeconomic status,
- negative medical history
Exclusion Criteria:
- Patients with a herpes infection in the dry desquamation stage will be excluded.
- Participants in continuous use of non-steroidal anti-inflammatory drugs and continued corticosteroid therapy for less than 1 week.
- Diabetic participants, smokers
- who need immunosuppressants,
- pregnant women and/or nursing mothers.
- HIV positive,
- hepatitis B or C.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Control (placebo)
experimental group
The patients will receive an agent with the same vehicle as methylene blue to mimic irrigation with the photosensitizer and the laser will be switched off at the time of application. The placebo PDT procedures will be performed on the lesion: Application of methylene blue placebo with a carpule syringe and needle (with stop and without bevel) inside the lesions; 1 minute of pre-irradiation will be expected. The irradiations will be performed with the same device positioned in the same way and at the same time of application, however, the laser will be turned off. The beep sound will be recorded and turned on during application to blind treatment to the patient. The patient will receive a catheter with acyclovir cream and will be advised to spread on the lesions four times a day for 7 days, which will be their return for reevaluation. It will be washed in abundance with saline (saline solution) until the total removal of the placebo from the photosensitizer.
Patients will be treated with photodynamic therapy and will receive a placebo ointment simulating acyclovir cream. If the lesions are in the vesicle phase, they will be ruptured with a sterile needle. The methylene blue solution at 0.005% concentration will be gently placed on the lesions. Application of methylene blue on the lesions.1 minute of pre-irradiation will be expected. The irradiations will be performed with the Laser Duo® with a wavelength of 660 nm, with a power of 100 mW(milliwatts), the energy density of 300 J / cm², with the energy of 3 J (joules) in the center of the lesion for 30 seconds. The laser will be positioned in direct contact with the lesion, perpendicular, applied centrally to each lesion with energy per point of 3J. Wash in abundance with saline solution until the removal of the photosensitizer is complete. Patients will receive a tube with a placebo cream simulating aciclovir and the same will be advised to spread the cream 4 times per day for 7 days.